Smiths Group PLC
26 September 2007
Smiths Group announces over US$45 million of new contracts from Smiths Medical
Smiths Group, the global technology company, today announces contracts won by
Smiths Medical with a total value of over US$45 million.
The contracts have been won in the last two months by Smiths Medical's Critical
Care business, which provides safety needles and catheters, temperature
management, airway and anaesthesia products to the US and international markets.
The contracts include:
• A renewal of a contract with a major Group Purchasing Organisation (GPO)
for IV catheters for the US hospital market, worth $30m
• A further contract with the same GPO for hypodermic needles worth $5m
• Additional new and secured contracts with GPO customers covering Arterial
Blood Gas sampling kits, circuits and masks (anaesthesia) and
hyperinflation (resuscitation) worth almost $11m
The contracts have a duration of either two or three years.
Srini Seshadri, Group Managing Director for Smiths Medical, said: 'We have had
an excellent start to the year in our Critical Care business, and continue to
win new agreements while securing relationships with the largest customers in
the market, which is a testament to the quality of our product ranges, and the
people who sell them.'
ENDS
About Smiths Medical
Smiths Medical is a supplier of specialist medical devices to global markets.
Smiths Medical comprises three product groupings: Critical Care, Safety Devices
and Medication Delivery & Patient Monitoring. Smiths Medical customers include
hospitals and other healthcare providers worldwide. Smiths Medical employs
nearly 7,500 people. For further information visit www.smiths-medical.com
About Smiths Group
Smiths is a global technology company listed on the London Stock Exchange. A
world leader in the practical application of advanced technologies, Smiths Group
delivers products and services for the threat & contraband detection, medical
devices, energy and communications markets worldwide. Our products and services
make the world safer, healthier and more productive. Smiths Group employs more
than 20,000 people in over 50 countries. For more information visit
www.smiths.com
Investor Relations Media
Russell Plumley Chris Fox
+44 (0)20 8457 8203 +44 (0)20 8457 8403
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.